ALPHA (psychedelic)
From Self-sufficiency
This article is an orphan, as few or no other articles link to it. Please introduce links to this page from related articles; suggestions may be available. (December 2008) |
File:ALPHA.png | |
Systematic (IUPAC) name | |
---|---|
1-(1,3-benzodioxol-5-yl)propan-1-amine | |
Clinical data | |
Routes of administration | Oral |
Pharmacokinetic data | |
Metabolism | Hepatic |
Excretion | Renal |
Identifiers | |
CAS Number | 127292-42-6 |
ATC code | none |
ChemSpider | 11853242 |
Chemical data | |
Formula | C10H13NO2 |
Molar mass | 179.216 g/mol[[Script error: No such module "String".]] |
Script error: No such module "collapsible list". | |
(verify) |
ALPHA or alpha-ethyl-3,4-methylenedioxybenzylamine, is a lesser-known psychedelic drug and a substituted benzylamine. It is also the benzylamine analogue of MDA. ALPHA was first synthesized by Alexander Shulgin. In his book PIHKAL (Phenethylamines I Have Known and Loved) in the MDA page, the threshold dosage is listed as 10 mg. At mild threshold dosages (around 10 mg) there are eyes-closed "dreams" with some body tingling, at higher doses (up to 140 mg) was reported to produce a pleasant, positive feeling. This compound is not anoretic at any dose. It lasts about 3 hours. Very little data exists about the pharmacological properties, metabolism, and toxicity of ALPHA.
See also
External links
This psychoactive drug-related article is a stub. You can help ssf by expanding it. |
Categories:
- Pages with script errors
- Pages with broken file links
- Orphaned articles from December 2008
- Articles with invalid date parameter in template
- All orphaned articles
- Infobox drug tracked parameters
- Articles without EBI source
- Chemical pages without DrugBank identifier
- Articles without KEGG source
- Articles without InChI source
- Articles without UNII source
- Drugs not assigned an ATC code
- Drugs with no legal status
- 2Fix
- Psychedelic drugs
- Psychoactive drug stubs